Roche Holdings AG Basel ADR (OTCMKTS:RHHBY) Receives Average Rating of “Hold” from Brokerages

Roche Holdings AG Basel ADR (OTCMKTS:RHHBY) has been given a consensus recommendation of “Hold” by the nine ratings firms that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $37.00.

Several research analysts have recently weighed in on the company. UBS Group raised Roche Holdings AG Basel from a “neutral” rating to a “buy” rating in a research report on Friday, July 26th. ValuEngine lowered Roche Holdings AG Basel from a “hold” rating to a “sell” rating in a research report on Tuesday, September 10th.

Several hedge funds have recently bought and sold shares of the company. Schaper Benz & Wise Investment Counsel Inc. WI raised its position in shares of Roche Holdings AG Basel by 0.3% in the 3rd quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 142,790 shares of the company’s stock worth $5,205,000 after acquiring an additional 400 shares in the last quarter. Everett Harris & Co. CA raised its position in shares of Roche Holdings AG Basel by 2.7% in the 2nd quarter. Everett Harris & Co. CA now owns 16,105 shares of the company’s stock worth $565,000 after acquiring an additional 428 shares in the last quarter. Sky Investment Group LLC raised its position in shares of Roche Holdings AG Basel by 0.7% in the 2nd quarter. Sky Investment Group LLC now owns 63,466 shares of the company’s stock worth $2,228,000 after acquiring an additional 445 shares in the last quarter. Pillar Pacific Capital Management LLC increased its position in Roche Holdings AG Basel by 0.4% in the 2nd quarter. Pillar Pacific Capital Management LLC now owns 157,843 shares of the company’s stock valued at $5,558,000 after buying an additional 565 shares in the last quarter. Finally, Diversified Trust Co increased its position in Roche Holdings AG Basel by 1.2% in the 2nd quarter. Diversified Trust Co now owns 48,764 shares of the company’s stock valued at $1,717,000 after buying an additional 599 shares in the last quarter. 0.32% of the stock is owned by hedge funds and other institutional investors.

Shares of RHHBY stock traded down $0.16 during mid-day trading on Friday, hitting $38.07. The company’s stock had a trading volume of 884,028 shares, compared to its average volume of 1,238,856. The company’s fifty day simple moving average is $36.88 and its 200-day simple moving average is $34.93. Roche Holdings AG Basel has a 52 week low of $29.45 and a 52 week high of $38.32. The company has a market cap of $262.30 billion, a PE ratio of 16.48, a P/E/G ratio of 2.39 and a beta of 0.50.

Roche Holdings AG Basel Company Profile

Roche Holding AG engages in the diagnostics and prescription pharmaceuticals businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anaemia, anticoagulation therapy, bone, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid and liver disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus and infectious diseases.

See Also: Swap

Analyst Recommendations for Roche Holdings AG Basel (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Holdings AG Basel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holdings AG Basel and related companies with MarketBeat.com's FREE daily email newsletter.